[HTML][HTML] SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
M Di Filippo, D Ferraro, P Ragonese, L Prosperini… - Journal of …, 2024 - Springer
Background COVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose.
M Di Filippo, D Ferraro, P Ragonese… - Journal of …, 2023 - europepmc.org
Background COVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
M Di Filippo, D Ferraro, P Ragonese… - JOURNAL OF …, 2024 - iris.unito.it
BackgroundCOVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
M Di Filippo, D Ferraro, P Ragonese… - JOURNAL OF …, 2024 - ricerca.unich.it
BackgroundCOVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
M Di Filippo, D Ferraro, P Ragonese… - JOURNAL OF …, 2023 - iris.univr.it
Background: COVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
M Di Filippo, D Ferraro, P Ragonese… - JOURNAL OF …, 2024 - iris.unipa.it
Background: COVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
[HTML][HTML] SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
M Di Filippo, D Ferraro, P Ragonese… - Journal of …, 2024 - ncbi.nlm.nih.gov
Background COVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
M Di Filippo, D Ferraro, P Ragonese… - JOURNAL OF …, 2024 - iris.unica.it
Background: COVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
M Di Filippo, D Ferraro, P Ragonese… - Journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Background COVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
M Di Filippo, D Ferraro, P Ragonese… - JOURNAL OF …, 2024 - iris.unicampania.it
Background: COVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …